Manulife (Manufacturers Life Insurance)
PRCT icon

Manulife (Manufacturers Life Insurance)’s Procept Biorobotics PRCT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
53,295
-6,232
-10% -$156K ﹤0.01% 1873
2026
Q1 		$1.49M Sell
59,527
-4,694
-7% -$132K ﹤0.01% 1622
2025
Q4 		$2.02M Sell
64,221
-8,676
-12% -$288K ﹤0.01% 1514
2025
Q3 		$2.6M Sell
72,897
-22,405
-24% -$1.02M ﹤0.01% 1419
2025
Q2 		$5.49M Buy
95,302
+23,049
+32% +$1.3M ﹤0.01% 1122
2025
Q1 		$4.21M Buy
72,253
+6,433
+10% +$439K ﹤0.01% 1237
2024
Q4 		$5.3M Buy
65,820
+6,785
+11% +$580K ﹤0.01% 1179
2024
Q3 		$4.73M Sell
59,035
-3,527
-6% -$251K ﹤0.01% 1236
2024
Q2 		$3.82M Sell
62,562
-10,469
-14% -$623K ﹤0.01% 1278
2024
Q1 		$3.61M Buy
73,031
+2,665
+4% +$127K ﹤0.01% 1314
2023
Q4 		$2.95M Sell
70,366
-12,590
-15% -$429K ﹤0.01% 1348
2023
Q3 		$2.72M Buy
82,956
+14,088
+20% +$480K ﹤0.01% 1342
2023
Q2 		$2.43M Buy
68,868
+8,729
+15% +$289K ﹤0.01% 1351
2023
Q1 		$1.71M Buy
60,139
+5,367
+10% +$189K ﹤0.01% 1441
2022
Q4 		$2.25M Buy
54,772
+260
+0.5% +$11.2K ﹤0.01% 1351
2022
Q3 		$2.22M Sell
54,512
-14,349
-21% -$572K ﹤0.01% 1357
2022
Q2 		$2.21M Buy
68,861
+12,694
+23% +$462K ﹤0.01% 1397
2022
Q1 		$1.95M Buy
+56,167
New +$1.35M ﹤0.01% 1515

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRCT Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Procept Biorobotics (PRCT) stake by 10% in Q2 2026, selling an estimated $156K and leaving 53,295 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1873.

Manulife (Manufacturers Life Insurance) first reported a position in PRCT in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.49M in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 53,295 shares of Procept Biorobotics worth $1.2M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 6,232 Procept Biorobotics shares in Q2 2026, an estimated $156K.
  • Procept Biorobotics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1873 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Procept Biorobotics in Q1 2022 and has held it in 18 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Procept Biorobotics position peaked at $5.49M in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.